These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21787232)

  • 41. Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models.
    Song Y; Morales L; Malik AS; Mead AF; Greer CD; Mitchell MA; Petrov MT; Su LT; Choi ME; Rosenblum ST; Lu X; VanBelzen DJ; Krishnankutty RK; Balzer FJ; Loro E; French R; Propert KJ; Zhou S; Kozyak BW; Nghiem PP; Khurana TS; Kornegay JN; Stedman HH
    Nat Med; 2019 Oct; 25(10):1505-1511. PubMed ID: 31591596
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression profiling of disease progression in canine model of Duchenne muscular dystrophy.
    Brinkmeyer-Langford C; Chu C; Balog-Alvarez C; Yu X; Cai JJ; Nabity M; Kornegay JN
    PLoS One; 2018; 13(3):e0194485. PubMed ID: 29554127
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multi-parametric MRI at 14T for muscular dystrophy mice treated with AAV vector-mediated gene therapy.
    Park J; Wicki J; Knoblaugh SE; Chamberlain JS; Lee D
    PLoS One; 2015; 10(4):e0124914. PubMed ID: 25856443
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of disease severity in a Canine Model of Duchenne Muscular Dystrophy: Classification of Quantitative MRI.
    Eresen A; Alic L; Kornegay J; Ji JX
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():648-651. PubMed ID: 30440480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Translating golden retriever muscular dystrophy microarray findings to novel biomarkers for cardiac/skeletal muscle function in Duchenne muscular dystrophy.
    Galindo CL; Soslow JH; Brinkmeyer-Langford CL; Gupte M; Smith HM; Sengsayadeth S; Sawyer DB; Benson DW; Kornegay JN; Markham LW
    Pediatr Res; 2016 Apr; 79(4):629-36. PubMed ID: 26672735
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular dystrophy dog.
    Zucconi E; Valadares MC; Vieira NM; Bueno CR; Secco M; Jazedje T; da Silva HC; Vainzof M; Zatz M
    Neuromuscul Disord; 2010 Jan; 20(1):64-70. PubMed ID: 19944604
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morphological and ultrastructural evaluation of the golden retriever muscular dystrophy trachea, lungs, and diaphragm muscle.
    Lessa TB; de Abreu DK; Rodrigues MN; Brólio MP; Miglino MA; Ambrósio CE
    Microsc Res Tech; 2014 Nov; 77(11):857-61. PubMed ID: 25081087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel canine model for Duchenne muscular dystrophy (DMD): single nucleotide deletion in DMD gene exon 20.
    Mata López S; Hammond JJ; Rigsby MB; Balog-Alvarez CJ; Kornegay JN; Nghiem PP
    Skelet Muscle; 2018 May; 8(1):16. PubMed ID: 29843823
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy.
    Kornegay JN; Peterson JM; Bogan DJ; Kline W; Bogan JR; Dow JL; Fan Z; Wang J; Ahn M; Zhu H; Styner M; Guttridge DC
    Skelet Muscle; 2014; 4():18. PubMed ID: 25789154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laminin-111 protein therapy enhances muscle regeneration and repair in the GRMD dog model of Duchenne muscular dystrophy.
    Barraza-Flores P; Fontelonga TM; Wuebbles RD; Hermann HJ; Nunes AM; Kornegay JN; Burkin DJ
    Hum Mol Genet; 2019 Aug; 28(16):2686-2695. PubMed ID: 31179490
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional improvement of dystrophic muscle by myostatin blockade.
    Bogdanovich S; Krag TO; Barton ER; Morris LD; Whittemore LA; Ahima RS; Khurana TS
    Nature; 2002 Nov; 420(6914):418-21. PubMed ID: 12459784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy.
    Kemaladewi DU; Hoogaars WM; van Heiningen SH; Terlouw S; de Gorter DJ; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; ten Dijke P; 't Hoen PA
    BMC Med Genomics; 2011 Apr; 4():36. PubMed ID: 21507246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-Targeted Metabolomics Analysis of Golden Retriever Muscular Dystrophy-Affected Muscles Reveals Alterations in Arginine and Proline Metabolism, and Elevations in Glutamic and Oleic Acid In Vivo.
    Abdullah M; Kornegay JN; Honcoop A; Parry TL; Balog-Alvarez CJ; O'Neal SK; Bain JR; Muehlbauer MJ; Newgard CB; Patterson C; Willis MS
    Metabolites; 2017 Jul; 7(3):. PubMed ID: 28758940
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safe and bodywide muscle transduction in young adult Duchenne muscular dystrophy dogs with adeno-associated virus.
    Yue Y; Pan X; Hakim CH; Kodippili K; Zhang K; Shin JH; Yang HT; McDonald T; Duan D
    Hum Mol Genet; 2015 Oct; 24(20):5880-90. PubMed ID: 26264580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expiratory dysfunction in young dogs with golden retriever muscular dystrophy.
    Hawkins EC; Bettis AK; Kornegay JN
    Neuromuscul Disord; 2020 Nov; 30(11):930-937. PubMed ID: 33071066
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength.
    Martin PT; Zygmunt DA; Ashbrook A; Hamilton S; Packer D; Birch SM; Bettis AK; Balog-Alvarez CJ; Guo LJ; Nghiem PP; Kornegay JN
    PLoS One; 2021; 16(3):e0248721. PubMed ID: 33770101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Whole body skeletal muscle transduction in neonatal dogs with AAV-9.
    Yue Y; Shin JH; Duan D
    Methods Mol Biol; 2011; 709():313-29. PubMed ID: 21194038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression.
    Wang Z; Kuhr CS; Allen JM; Blankinship M; Gregorevic P; Chamberlain JS; Tapscott SJ; Storb R
    Mol Ther; 2007 Jun; 15(6):1160-6. PubMed ID: 17426713
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs.
    Kornegay JN; Li J; Bogan JR; Bogan DJ; Chen C; Zheng H; Wang B; Qiao C; Howard JF; Xiao X
    Mol Ther; 2010 Aug; 18(8):1501-8. PubMed ID: 20517298
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alteration of cardiac progenitor cell potency in GRMD dogs.
    Cassano M; Berardi E; Crippa S; Toelen J; Barthelemy I; Micheletti R; Chuah M; Vandendriessche T; Debyser Z; Blot S; Sampaolesi M
    Cell Transplant; 2012; 21(9):1945-67. PubMed ID: 22513051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.